Go Pro

Research Solutions Targets AI-Driven Growth as High-Margin SaaS Revenue Rises

Research Solutions logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Research Solutions is embedding AI into its Scite and Article Galaxy products through connectors for Microsoft Copilot, Claude and ChatGPT, enabling researchers to find, access and manage scientific content while addressing copyright and licensing requirements.
  • AI connectors are creating larger enterprise sales opportunities, including high-five-figure, six-figure and proposed seven-figure deals, though IT security reviews and corporate AI approvals are lengthening sales cycles.
  • The company’s shift toward high-margin SaaS is improving its financial profile: software now represents about 43% of revenue, platform gross margins exceed 85%, and management reported $6 million in trailing-12-month EBITDA alongside more than $12 million in cash and no debt.
  • Five stocks we like better than Research Solutions.

Research Solutions NASDAQ: RSSS outlined its strategy to expand its scientific research platform through artificial intelligence integrations, while continuing a multiyear shift toward higher-margin subscription software revenue.

Chief Executive Officer and Chairman Roy Olivier said the company primarily serves corporate research organizations, which account for more than 80% of its revenue. The remaining revenue comes from government and academic institutions, including university libraries. Research Solutions provides tools used by organizations to find, acquire, manage and share peer-reviewed scientific research while maintaining copyright compliance.

Olivier said the company’s platform supports research workflows across industries, with customers including Bayer, BASF and L’Oréal. Research Solutions also serves customers in pharmaceutical, medical-device and biotechnology markets, which together generate about half of its revenue, according to Olivier.

AI integrations target research workflows

Research Solutions has shifted its product strategy over the past year toward connecting its Scite and Article Galaxy products with large language model platforms, including Microsoft Copilot, Claude and ChatGPT.

Scite is the company’s research discovery product, while Article Galaxy provides access to scientific documents and helps customers manage subscriptions, corporate-library holdings and usage rights. Olivier said the integrations allow users to begin research queries within an AI tool and then access content, citations and document-delivery capabilities through Research Solutions’ products.

“Our strategy shifted about a year ago from focusing exclusively on platform development to how do we be where our customer is?” Olivier said. “They’re going to be in these LLMs.”

He said the company released two connector products within the past several months: one connecting Scite to AI tools and another connecting Article Galaxy to those platforms. The tools are intended to help researchers obtain more detailed answers than AI systems can provide using only publicly accessible article abstracts, while allowing customers to acquire underlying documents through existing subscriptions, library holdings, open-access sources or individual purchases.

Olivier said copyright compliance is a significant consideration for corporate customers, particularly in North America and Europe. Through Article Galaxy, users can determine whether their organization already has access rights to an article, whether it can be reused within the organization, and whether rights permit AI-related uses such as summarization or extracting information.

The company has relationships with approximately 2,900 publishers, Olivier said, and has AI-related rights covering about 60% of global scientific content. He argued that publishers are unlikely to broadly license all paywalled scientific content to large language model providers because that content remains a substantial source of subscription revenue.

Larger sales opportunities, longer sales cycles

Olivier said the newer AI connector products have increased the size of some sales opportunities, though they have also extended sales cycles because deployments require IT security reviews and discussions with corporate AI committees.

Historically, the average sale for Scite and Article Galaxy has been about $11,000 to $12,000, he said. The company has closed several high-five-figure and six-figure connector deals, according to Olivier, and has proposals in the high-six-figure range as well as one seven-figure proposal.

Research Solutions has about 1,000 corporate customers, Olivier said. He described the company’s workflow integrations as difficult to replace once installed, noting that its customer agreements commonly span three to five years. Average customer lifetime value exceeds seven years, he said, while larger customers can remain with the company for more than a decade.

The company estimates its business-to-business market opportunity at about $4 billion, focusing on research-intensive corporations and academic institutions. While Research Solutions also has a business-to-consumer subscription offering, Olivier said the company’s strategic emphasis is on enterprise customers because of their potentially more durable revenue characteristics.

Subscription mix supports margin and cash-flow improvement

Olivier said Research Solutions has been transitioning from a transaction-based document-delivery business to a SaaS-focused model. The document-delivery business has gross margins of roughly 24% to 25% and generates cash flow that supports software investments, while the platform business carries gross margins above 85%, he said.

Software represented approximately 43% of company revenue, up from 39% a year earlier, according to Chief Financial Officer Dave Kutil. Platform annual recurring revenue increased from about $9 million to roughly $22 million over four years, Kutil said.

Kutil said the revenue mix shift reached an inflection point in fiscal 2023, when the company began generating profitable operations and cash flow. He said the company generated $6 million of EBITDA over the previous 12 months and expects to approximately double net income year over year.

Research Solutions had more than $12 million in cash, no debt and an untapped line of credit, Kutil said. The company has made about $7 million of earn-out payments over the past five quarters and has three payments remaining, which he said are expected to be completed by the end of the company’s fiscal year ending June 2027.

Olivier said transactional document-delivery revenue has faced pressure from customer losses, budget constraints and workforce reductions in pharmaceutical markets. The company expects a low-single-digit decline in transactional revenue during the next year before anticipating a return to either slight declines or slight growth, depending on economic conditions and internal initiatives.

On capital allocation, Olivier said Research Solutions has reviewed hundreds of acquisition targets and completed two acquisitions plus a customer purchase during his tenure. However, he said management has slowed its M&A activity while evaluating how AI may affect potential targets. The company is also discussing potential uses for its cash balance, including buybacks, dividends and investments in growth.

About Research Solutions (NASDAQ:RSSS)

Research Solutions, Inc NASDAQ: RSSS is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company's flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.

Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Research Solutions Right Now?

Before you consider Research Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.

While Research Solutions currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines